Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 225 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 225 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride provides potassium ions for maintaining intracellular tonicity, cellular metabolism, nerve impulse transmission, and muscle contraction. Dextrose 5% provides a source of calories and water for hydration. Sodium chloride 0.225% provides sodium and chloride ions to maintain electrolyte balance and osmotic pressure.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion at a rate not exceeding 10 mEq/hour; typical dose 10-20 mEq over 1-2 hours, may repeat as needed. Maximum 40 mEq per dose, 200 mEq per day.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Potassium has no defined terminal elimination half-life as it is an electrolyte regulated by homeostasis; redistribution half-life is approximately 4–6 hours. In renal impairment, elimination is prolonged.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal excretion: potassium is primarily eliminated by the kidneys; approximately 90% of potassium intake is excreted renally, with the remainder via feces (10%) and negligible biliary elimination.
Category C
Category A/B
Electrolyte
Electrolyte